These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 19715280)

  • 1. Heterogeneous nuclear ribonucleoprotein A1 is identified as a potential biomarker for colorectal cancer based on differential proteomics technology.
    Ma YL; Peng JY; Zhang P; Huang L; Liu WJ; Shen TY; Chen HQ; Zhou YK; Zhang M; Chu ZX; Qin HL
    J Proteome Res; 2009 Oct; 8(10):4525-35. PubMed ID: 19715280
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Proteomics identification of desmin as a potential oncofetal diagnostic and prognostic biomarker in colorectal cancer.
    Ma Y; Peng J; Liu W; Zhang P; Huang L; Gao B; Shen T; Zhou Y; Chen H; Chu Z; Zhang M; Qin H
    Mol Cell Proteomics; 2009 Aug; 8(8):1878-90. PubMed ID: 19460759
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Heterogeneous nuclear ribonucleoprotein K (hnRNP K) is a tissue biomarker for detection of early hepatocellular carcinoma in patients with cirrhosis.
    Guo Y; Zhao J; Bi J; Wu Q; Wang X; Lai Q
    J Hematol Oncol; 2012 Jul; 5():37. PubMed ID: 22760167
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Up-regulation of hnRNP A1, Ezrin, tubulin β-2C and Annexin A1 in sentinel lymph nodes of colorectal cancer.
    He ZY; Wen H; Shi CB; Wang J
    World J Gastroenterol; 2010 Oct; 16(37):4670-6. PubMed ID: 20872967
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Overexpression of HnRNP A1 promotes tumor invasion through regulating CD44v6 and indicates poor prognosis for hepatocellular carcinoma.
    Zhou ZJ; Dai Z; Zhou SL; Fu XT; Zhao YM; Shi YH; Zhou J; Fan J
    Int J Cancer; 2013 Mar; 132(5):1080-9. PubMed ID: 22821376
    [TBL] [Abstract][Full Text] [Related]  

  • 6. microRNA-26a and -584 inhibit the colorectal cancer progression through inhibition of the binding of hnRNP A1-CDK6 mRNA.
    Konishi H; Fujiya M; Ueno N; Moriichi K; Sasajima J; Ikuta K; Tanabe H; Tanaka H; Kohgo Y
    Biochem Biophys Res Commun; 2015 Nov; 467(4):847-52. PubMed ID: 26494299
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of HnRNP M as a novel biomarker for colorectal carcinoma by quantitative proteomics.
    Chen S; Zhang J; Duan L; Zhang Y; Li C; Liu D; Ouyang C; Lu F; Liu X
    Am J Physiol Gastrointest Liver Physiol; 2014 Mar; 306(5):G394-403. PubMed ID: 24381081
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aptamer BC15 against heterogeneous nuclear ribonucleoprotein A1 has potential value in diagnosis and therapy of hepatocarcinoma.
    Li S; Wang W; Ding H; Xu H; Zhao Q; Li J; Li H; Xia W; Su X; Chen Y; Fang T; Shao N; Zhang H
    Nucleic Acid Ther; 2012 Dec; 22(6):391-8. PubMed ID: 23062008
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HnRNP K and PDI marked response to chemotherapy to human colorectal cancer cells.
    Zhang P; Huang L; Ma YL; Peng JY; Shen TY; Chen HQ; Zhou YK; Zhang M; Chu ZX; Qin HL
    Electrophoresis; 2010 May; 31(10):1731-8. PubMed ID: 20408130
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of prohibitin as a potential biomarker for colorectal carcinoma based on proteomics technology.
    Chen D; Chen F; Lu X; Yang X; Xu Z; Pan J; Huang Y; Lin H; Chi P
    Int J Oncol; 2010 Aug; 37(2):355-65. PubMed ID: 20596663
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A rat-to-human search for proteomic alterations reveals transgelin as a biomarker relevant to colorectal carcinogenesis and liver metastasis.
    Peng J; Zhang Q; Ma Y; Wang Y; Huang L; Zhang P; Chen J; Qin H
    Electrophoresis; 2009 Sep; 30(17):2976-2987. PubMed ID: 19711377
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Proteomic profiling of proteins associated with lymph node metastasis in colorectal cancer.
    Ma Y; Zhao M; Zhong J; Shi L; Luo Q; Liu J; Wang J; Yuan X; Huang C
    J Cell Biochem; 2010 Aug; 110(6):1512-9. PubMed ID: 20524204
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of differentially-expressed proteins between early submucosal non-invasive and invasive colorectal cancer using 2D-DIGE and mass spectrometry.
    Zhang J; Song MQ; Zhu JS; Zhou Z; Xu ZP; Chen WX; Chen NW
    Int J Immunopathol Pharmacol; 2011; 24(4):849-59. PubMed ID: 22230392
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of HSP27 as a potential tumor marker for colorectal cancer by the two-dimensional polyacrylamide gel electrophoresis.
    Liu W; Ma Y; Huang L; Peng J; Zhang P; Zhang H; Chen J; Qin H
    Mol Biol Rep; 2010 Oct; 37(7):3207-16. PubMed ID: 19842058
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Up-regulation of hnRNP A1 gene in sporadic human colorectal cancers.
    Ushigome M; Ubagai T; Fukuda H; Tsuchiya N; Sugimura T; Takatsuka J; Nakagama H
    Int J Oncol; 2005 Mar; 26(3):635-40. PubMed ID: 15703818
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Heterogeneous nuclear ribonucleoprotein A2/B1 in association with hTERT is a potential biomarker for hepatocellular carcinoma.
    Mizuno H; Honda M; Shirasaki T; Yamashita T; Yamashita T; Mizukoshi E; Kaneko S
    Liver Int; 2012 Aug; 32(7):1146-55. PubMed ID: 22372738
    [TBL] [Abstract][Full Text] [Related]  

  • 17. microRNA-18a induces apoptosis in colon cancer cells via the autophagolysosomal degradation of oncogenic heterogeneous nuclear ribonucleoprotein A1.
    Fujiya M; Konishi H; Mohamed Kamel MK; Ueno N; Inaba Y; Moriichi K; Tanabe H; Ikuta K; Ohtake T; Kohgo Y
    Oncogene; 2014 Oct; 33(40):4847-56. PubMed ID: 24166503
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of apoptosis-associated proteins in a human Burkitt lymphoma cell line. Cleavage of heterogeneous nuclear ribonucleoprotein A1 by caspase 3.
    Brockstedt E; Rickers A; Kostka S; Laubersheimer A; Dörken B; Wittmann-Liebold B; Bommert K; Otto A
    J Biol Chem; 1998 Oct; 273(43):28057-64. PubMed ID: 9774422
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stroma derived COL6A3 is a potential prognosis marker of colorectal carcinoma revealed by quantitative proteomics.
    Qiao J; Fang CY; Chen SX; Wang XQ; Cui SJ; Liu XH; Jiang YH; Wang J; Zhang Y; Yang PY; Liu F
    Oncotarget; 2015 Oct; 6(30):29929-46. PubMed ID: 26338966
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of serum biomarkers for colorectal cancer metastasis using a differential secretome approach.
    Xue H; Lü B; Zhang J; Wu M; Huang Q; Wu Q; Sheng H; Wu D; Hu J; Lai M
    J Proteome Res; 2010 Jan; 9(1):545-55. PubMed ID: 19924834
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.